Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV).

Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV). Clin Cancer Res. 1999 Mar; 5(3):655-63.

View in: PubMed

subject areas

Antineoplastic Agents
Cell Cycle
Cell Survival
Cisplatin
Cyclin-Dependent Kinase Inhibitor p21
Cyclins
Drug Resistance, Neoplasm
Female
G1 Phase
Humans
Organoplatinum Compounds
Ovarian Neoplasms
Tumor Cells, Cultured
Tumor Suppressor Protein p53

authors with profiles

ROBERT C BAST JR
ZAHID H SIDDIK
GORDON B MILLS